Riskpilot← Back to searchSign inGet full accessKernell Medical AB
ABActiveOrg 5569932964General medical practice activities · NACE 8621Est. 20140 employees
Revenue 2025
—
EBITDA margin
—
-263% vs 2024
Equity ratio
-301.9%
Financial strength
Net profit 2025
SEK -22K
-264% vs 2024
| Revenue | — | — |
| EBITDA | SEK -23K | -263% |
| Net profit | SEK -22K | -264% |
| Total assets | SEK 4K | +0% |
| Equity | SEK -13K | +23% |
| Employees | 0 | — |
Legal name
Kernell Medical AB
Org number
5569932964
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
2 december 2014
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av ledamoten Styrelsen ska bestå av 1 styrelseledamot och 1 styrelsesuppleant.
Company purpose
Bolaget ska bedriva hälso- och sjukvård samt därmed förenlig verksamhet.
Address
Email
per-juan.kernell@orthocenter.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | — | — |
| Staff expenses | — | — | — | — | — |
| EBITDA | −1 | −1 | −22 | −6 | −22 |
| Depreciation & amort. | — | — | — | — | — |
| EBIT | −1 | −1 | −22 | −6 | −22 |
| Net financials | −13 | −0 | −1 | 0 | 0 |
| Profit before tax | −15 | −1 | −22 | −6 | −22 |
| Tax | — | — | — | — | — |
| Net profit | −15 | −1 | −22 | −6 | −22 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 28 | 27 | 5 | 4 | 4 |
| Equity | 13 | 12 | −11 | −17 | −13 |
| Long-term debt | — | — | — | — | — |
| Short-term debt | 15 | 15 | 16 | 21 | 18 |
| Total debt | 15 | 15 | 16 | 21 | 18 |
EBITDA margin
-2250000.0%
This company
15.8%
Market median
-14240606% vs market
20212025
Equity ratio
-301.9%
This company
38.2%
Market median
-890% vs market
20212025
Return on equity
-2249000.0%
This company
18.4%
Market median
-12222926% vs market
20212025
Net profit margin
-2249000.0%
This company
8.1%
Market median
-27765532% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
1.33×
This company
0.62×
Market median
-115% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2021 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2026 | |
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Kernell Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per-Juan Ludvig Mendoza Kernell | Board of Directors | 0 companies |
| Daniel Olof Robert Mendoza Kernell | Deputy Board Member | 0 companies |
| Sigrid Eleonora Adela Zbinden | Deputy Board Member | 0 companies |